Latest articles by Dr Mike Tubbs
-
How Finseta is cashing in on currencies
Finseta has established a foothold in the upper echelons of the market for international payments. Should you invest?
-
Relx outperforms: should you buy this FTSE 100 success story?
Relx, a fast-growing risk management and analytics group is benefiting from artificial intelligence
-
8 dividend super aristocrats to look out for
Share Tips Consider these dividend super aristocrats that have increased their payout for up to 60 years in a row.
Share Tips -
Diploma: a blue-chip set for strong growth
Diploma, whose niche products include seals and fasteners, serves an array of growth markets. Should you invest?
-
Why you should consider founder-led firms for your portfolio
Founder-led firms tend to outperform. Dr Mike Tubbs explains why and surveys the world’s equity markets to gauge which ones currently look the most appealing
-
Time to tuck in to McDonald’s
McDonald’s, the world’s largest restaurant chain, is a highly profitable business with plenty of room to grow.
-
9 stocks to buy for solid dividends
Dr Mike Tubbs singles out nine stocks poised to deliver strong earnings growth and solid dividends.
-
Buy stocks with wide moats to protect your profits
Tips Companies with wide "moats" – attributes that give them an enduring competitive advantage – tend to thrive over the long term. Dr Mike Tubbs explains how to identify them and how to invest in them.
Tips -
Why this biotech company has years of growth ahead
Analysis Zimmer Biomet, a leader in the worldwide market for hip and knee joints, enjoys a competitive advantage and has years of growth ahead, says Dr Mike Tubbs.
Analysis -
How to find the market’s “multi-bagger” stocks
Advice The success of major indices is based on a handful of spectacular performers. Dr Mike Tubbs outlines the key characteristics of shares capable of rising tenfold or more – and suggests where to start looking
Advice -
A UK-listed multinational engineer with strong growth and rising dividends
Tips Spirax-Sarco is a world-leading engineer making consistent progress in three niche markets, with an order book at an all-time high.
Tips -
Investing in drugmakers: uncommon profits from curing rare diseases
Cover Story Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors because of government incentives, says Dr Mike Tubbs.
Cover Story -
Raytheon Technologies: a safe stock for an unsafe world
Tips Defence spending is set to soar – that should be good news for aerospace heavyweight Raytheon Technologies.
Tips -
Veterinary medicine stocks: the firms keeping your pet healthy
Cover Story Pet ownership has grown due to the pandemic. That’s good news for animal health stocks, says Dr Mike Tubbs
Cover Story -
Adobe: a growth stock with a wide moat
Tips Adobe already dominates the creative industries – now it’s expanding into ecommerce
Tips -
The best vaccine-makers’ stocks to buy now
Cover Story The rapid development of Covid-19 vaccines has already saved many lives and made huge profits for a few pharmaceutical firms. Investors should keep an eye on other products in their pipelines, says Dr Mike Tubbs.
Cover Story -
Molten Ventures: invest in digital technology with this venture capitalist
Tips Molten Ventures offers investors access to fast-growing unlisted companies across Europe
Tips -
The nifty nine: a portfolio of stocks to buy and hold forever
Cover Story A diverse range of stocks you can buy and keep forever should be a core part of any equity portfolio, says Dr Mike Tubbs. He selects his nine favourites from sectors ranging from agriculture to scientific instruments.
Cover Story -
Duke Royalty: a princely return for income investors
Tips Britain’s only listed royalty-finance company chooses its clientele wisely, making it a compelling income play
Tips -
University spin-outs: where to find companies involved in cutting-edge science
Cover Story Universities are innovation incubators and often launch businesses involved in fast-growing fields ranging from biotechnology to artificial intelligence. Dr Mike Tubbs explains how to invest in their “spin-outs”
Cover Story -
Games Workshop: real profits from fantasy games
Tips Games Workshop, a long-established maker of wargames, has enormous potential for further growth.
Tips -
A great leap forward in the war against Alzheimer’s disease
Cover Story The approval of the first drug to treat the neurodegenerative disease in 18 years will galvanise research in the entire subsector, says Dr Mike Tubbs. That bodes well for Huntingdon’s and Parkinson’s sufferers too
Cover Story -
How to invest in biotechnology: the healthcare sector’s high-growth area
Cover Story Dr Mike Tubbs provides an overview of this thriving industry, whose latest triumphs include the Covid-19 vaccines. He examines the best investment strategies and highlights his favourite picks.
Cover Story -
Merck: the good value biotech stock that has cornered the cancer market
Tips Merck, the biopharma giant, dominates the biggest disease sector and looks reasonably valued, says Dr Mike Tubbs.
Tips
